Implementing Antagonist-Based Relapse Prevention Treatment for Buprenorphine-Treated Individuals PCSS-MAT Chat (No CME)

Loading Events

« All Events

  • This event has passed.

Implementing Antagonist-Based Relapse Prevention Treatment for Buprenorphine-Treated Individuals PCSS-MAT Chat (No CME)

April 29, 2014 @ 12:00 pm - 1:00 pm

Adam Bisaga, M.D. | Professor of Psychiatry Columbia University Medical Center, New York, NY

PCSS-MAT CHAT Description:
This presentation is designed to follow the Implementing Antagonist-Based Relapse Prevention Treatment for Buprenorphine-Treated Individuals Online Module with Case Vignette .  

Some questions discussed in this presentation:

  • Can patients be transitioned from methadone maintenance onto naltrexone?
  • How Does the Effectiveness of XR-naltrexone Compare to the Effectiveness of Other Treatments for opioid use disorder?
  • Can Patients be Transitioned from Methadone Maintenance Onto Naltrexone?

Additional Materials:

Naltrexone FAQs and Answers by Dr. Adam Bisaga

Preparation and Injection of Extended-Release Naltrexone (Vivitrol) Video 

Details

Date:
April 29, 2014
Time:
12:00 pm - 1:00 pm
Event Categories:
,

Other

Presenter
Adam Bisaga, M.D.
Presenter Details
Professor of Psychiatry Columbia University Medical Center, New York, NY
Watch Now
<a href="http://www.cvent.com/d/hrqw0k" target="self">http://www.cvent.com/d/hrqw0k</a>